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Abstract: Abstract  
Immunoglobulin (Ig) G4-related disease (IgG4-RD) is a new disease entity characterised by high serum 
IgG4 concentrations, infiltration of IgG4-positive plasmacytes and fibrosis of various organs. Several 
groups have reported that IgG4-RD is a unique inflammatory disorder characterised by an immune 
reaction predominantly mediated by T helper (Th) 2 and regulatory T (Treg) cells. Meanwhile, recent 
studies have demonstrated that interleukin (IL)-18 has a potential to trigger the production of Th2 
cytokines by Th1 cells. We analysed IL-18 expression in submandibular glands of patients with IgG4-
RD (20 cases) and controls (19 cases) by immunohistochemical analysis and quantitative real-time 
reverse transcription polymerase chain reaction (qRT-PCR). We found that IL-18 was highly expressed 
in submandibular glands of patients with IgG4-RD than in controls with both protein (p < 0.05, chi-
square test) and mRNA levels (p < 0.05, Mann-Whitney U test). In addition, the expression of IL-18 and 
IL-13 was correlated in submandibular glands of patients with IgG4-RD. Moreover, by analysing dual 
immunofluorescence staining, a few numbers of cells were double-positive for IL-13 and interferon 
(IFN)- 03B3 at the inflammatory infiltrates of submandibular glands of patients with IgG4-RD. These 
data suggest a possibility that IL-13 is produced by Th1 cells. We speculated that IL-18 stimulates Th1 







The pathogenesis of IgG4-RD remains largely unknown.  
IL-18 was highly expressed in submandibular glands of patients with IgG4-RD.  
We speculated that IL-18 acts as a reinforcement of Th2 cytokines in IgG4-RD.  
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Abstract  21 
Immunoglobulin (Ig) G4-related disease (IgG4-RD) is a new disease entity 22 
characterised by high serum IgG4 concentrations, infiltration of IgG4-positive 23 
plasmacytes and fibrosis of various organs. Several groups have reported that IgG4-RD 24 
is a unique inflammatory disorder characterised by an immune reaction predominantly 25 
mediated by T helper (Th) 2 and regulatory T (Treg) cells. Meanwhile, recent studies 26 
have demonstrated that interleukin (IL)-18 has a potential to trigger the production of 27 
Th2 cytokines by Th1 cells. We analysed IL-18 expression in submandibular glands of 28 
patients with IgG4-RD (20 cases) and controls (19 cases) by immunohistochemical 29 
analysis and quantitative real-time reverse transcription polymerase chain reaction 30 
(qRT-PCR). We found that IL-18 was highly expressed in submandibular glands of 31 
patients with IgG4-RD than in controls with both protein (p < 0.05, chi-square test) and 32 
mRNA levels (p < 0.05, Mann–Whitney U test). In addition, the expression of IL-18 33 
and IL-13 was correlated in submandibular glands of patients with IgG4-RD. Moreover, 34 
by analysing dual immunofluorescence staining, a few numbers of cells were 35 
double-positive for IL-13 and interferon (IFN)-at the inflammatory infiltrates of 36 
submandibular glands of patients with IgG4-RD. These data suggest a possibility that 37 
IL-13 is produced by Th1 cells. We speculated that IL-18 stimulates Th1 cells 38 
producing Th2 cytokines and enhances the immune reaction of Th2 cytokines in 39 
pathogenesis of IgG4-RD.  40 
 41 
1. Introduction  42 
Immunoglobulin (Ig) G4-related disease (IgG4-RD) is a new disease entity 43 
characterised by high serum IgG4 concentrations, infiltration of IgG4-positive 44 
plasmacytes and fibrosis of various organs such as the pancreas, bile duct, lung, liver, 45 
kidney, aorta, retroperitoneum and salivary glands [1-4]. The clinical features, 46 
including serum abnormalities, organ involvement, diagnosis and the therapeutic 47 
approach have been reported [1, 2]. However, the pathogenesis of this disease remains 48 
largely unknown.  49 
Several investigators have reported on aberrant immunological findings such 50 
as T helper (Th) 2-dominated cytokine production, leading to IgG4 hyperproduction 51 
and increase in the number of regulatory T (Treg) cells in IgG4-RD [5-10]. Meanwhile, 52 
it has been reported that Th2 cytokines such as interleukin (IL)-4 and IL-13 and Treg 53 
cytokines such as IL-10 could induce IgG4- and IgE-specific class-switch 54 
recombination. In addition, tumour growth factor (TGF)-, one of the Treg cytokines, 55 
can induce the development of tissue fibrosis, which is a unique pathological finding of 56 
IgG4-RD. Moreover, this tissue fibrosis develops in various organs. Thus, IgG4-RD is a 57 
unique inflammatory disease characterised by an immune reaction predominantly 58 
mediated by Th2 and Treg cells [5].  59 
In contrast, it is widely accepted that Th2 cytokines are principally responsible 60 
for inducing bronchial asthma [11, 12]. In particular, some studies have suggested that 61 
IL-18, a Th1 cytokine, is involved in the pathogenesis of certain types of bronchial 62 
asthma [13]. IL-18 was originally identified as a factor that enhances interferon (IFN)- 63 
production from Th1 cells [14, 15]. However, recent studies have demonstrated that 64 
IL-18 has a potential to induce the production of Th2 cytokines by Th1 cells [16]. 65 
Based on this unique function of Th1 cells, Nakanishi et al. proposed to designate them 66 
as ‘super Th1 cells’ [16]. Super Th1 cells may be involved in the pathogenesis of 67 
certain types of allergic disorders by producing both Th1 and Th2 cytokines.  68 
The objectives of this study were to evaluate IL-18 expression in IgG4-RD 69 
that could be closely associated with Th2 cytokines and to investigate the association of 70 
super Th1 cells for the pathogenesis of IgG4-RD.  71 
 72 
2. Materials and Methods 73 
2.1. Patients 74 
We obtained 20 specimens of submandibular glands from patients with 75 
IgG4-RD who had been diagnosed at the Division of Otolaryngology and Head and 76 
Neck Surgery at the Kanazawa University Hospital (Kanazawa, Japan) between 2003 77 
and 2012 (14 males and 6 females; age, 34–77 years). All 20 patients presented with 78 
symmetrical swelling of submandibular glands and underwent surgical resection for 79 
confirmed diagnosis of IgG4-RD. We used these resected specimens for the experiment 80 
in our study. The characteristics of these patients are shown in Table 1. All patients with 81 
IgG4-RD satisfied the comprehensive diagnostic criteria for IgG4-RD proposed by the 82 
All Japan IgG4 team in 2011 [17]. The diagnosis of IgG4-RD was based on the 83 
presence of the following three items: (1) clinical examination showing characteristic 84 
diffuse/localized swelling or masses in single or multiple organs; (2) hematologic 85 
examination showing elevated serum IgG4 concentrations (135 mg/dL); and (3) 86 
histopathologic examination showing (a) marked lymphocyte and plasmacyte 87 
infiltration and fibrosis and (b) infiltration of IgG4
+





cells >40% and >10 IgG4
+
 plasma cells/HPF).  89 
As controls, we obtained 19 specimens of lymph nodes (LNs) from patients 90 
with reactive lymph nodes who underwent LN dissection (9 males and 10 females aged 91 
20–82 years) and 30 specimens of submandibular glands from patients with 92 
sialolithiasis and pleomorphic adenoma who underwent surgical resection (17 males 93 
and 13 females aged 19–72 years). We labelled the two types of control cases as 94 
controls of LN and controls of submandibular glands. We excluded LNs of patients 95 
diagnosed with malignant diseases or lymphoma. The diagnosis was based on clinical 96 
data and pathological findings. Reactive lymph nodes had lymphoid follicles that were 97 
similar to lymphoid infiltrates of submandibular glands of patients with IgG4-RD 98 
according to the pathological finding. Controls of submandibular glands were 99 
diagnosed at the the Division of Otolaryngology at Kanazawa University Hospital 100 
between 1990 and 2012. Controls of LN were diagnosed between 2013 and 2014.  101 
The study was approved by the Ethics Committee of the Kanazawa University, 102 
and informed consent was obtained from each patient before enrolment.  103 
 104 
2.2. Laboratory Data  105 
 The serum samples were collected from patients at first presentation and stored 106 
at −80ºC until further processing. Serum Igs (IgG, IgG4, and IgE) were measured 107 
routinely.  108 
 109 
2.3. Immunohistochemical analysis of submandibular gland and lymph node 110 
tissues  111 
Specimens of submandibular glands for both IgG4-RD and controls and 112 
specimens of lymph nodes for controls were examined by immunohistochemical 113 
analysis of IgG, IgG4, IL-4, IL-13, IL-18 and IFN- expression. Three-µm-thick 114 
sections were prepared from each block of tissue embedded in paraffin. Deparaffinised 115 
sections were treated with 3% hydrogen peroxide for 10 min to inactivate endogenous 116 
peroxidase activity. The sections were incubated with protein blocker (Dako, Glostrup, 117 
Denmark) for 30 min and incubated at 4°C overnight with rabbit anti-human IgG 118 
antibody(1:5000, Dako), mouse anti-human IgG4 antibody (1:2000, Life technologies, 119 
Grand Island, NY), rabbit anti-human IL-18 antibody (PM014, 1:2000, Medical and 120 
Biological Laboratories CO., LTD., Nagoya, Japan), rabbit anti-human IL-13 antibody 121 
(06-1090, 1:200, MILLIPORE, MA, USA), rabbit anti-human IL-4 antibody (ab9622, 122 
1:200, Abcam, Cambridge, UK) and rabbit anti human IFN- antibody (ab9657, 1:500, 123 
Abcam) as primary antibodies. The sections were washed three times with 124 
phosphate-buffered saline (PBS, pH 7.2). After washing with PBS, the sections were 125 
exposed to Envision
+
 secondary antibody (Dako) for 30 min. The reaction products 126 
were developed by immersing the sections in a 3′3-diamidobenzidine 127 
tetrahydrochloride solution. The sections were counterstained with hematoxylin. 128 
 129 
2.4. Evaluation of the specimens 130 
We first examined IL-18 expression in specimens of submandibular glands of 131 
patients with IgG4-RD and control cases. Bombardieri et al. reported that IL-18 is 132 
expressed in ductal epithelial cells and periductal inflammatory foci of salivary glands 133 
in patients with Sjögren’s syndrome [18, 19, 20]. In this report, periductal mononuclear 134 
infiltrate was defined as an inflammatory focus when at least 50 mononuclear cells with 135 
focal organization were present. Meanwhile, it was reported that IL-18 expression was 136 
only observed in ductal epithelial cells from submandibular glands of patients with 137 
chronic sialoadenitis, but not in periductal inflammatory foci of patients with the same 138 
condition [18]. Therefore, we evaluated cytokine expression in inflammatory infiltrates 139 
of submandibular glands in the present study. According to similarity of pathological 140 
findings between inflammatory infiltrates of submandibular glands of patients with 141 
IgG4-RD and lymphoid follicle of LN, we evaluated cytokine expression in lymphoid 142 
follicles of LNs in controls of LN.  143 
The stained sections were independently evaluated by two investigators (T. K. 144 
and S. K.) who were blinded to the clinical data. After counting both immunoreactive 145 
lymphocytes and total number of lymphocytes at five different high-power fields (HPFs, 146 
400×) with intense inflammation, the average frequency of immunoreactive 147 
lymphocytes was calculated. The average percentage of immunoreactive lymphocytes 148 
was defined as the expression score and was used for statistical analysis. The cases 149 
were classified into negative and positive categories as follows: negative, <10% 150 
immunoreactive cells; positive, ≥10% immunoreactive cells.  151 
 152 
2.5. Quantitative real-time reverse transcription polymerase chain reaction 153 
(qRT-PCR) 154 
Total RNA was extracted from frozen tissues in cases of IgG4-RD (7 cases) 155 
and pleomorphic adenoma of submandibular glands (6 cases in controls of 156 
submandibular gland) using the RNeasy Plus Mini Kit (QIAGEN, Valencia, CA, USA). 157 
For real-time RT-PCR analysis, total RNA was reverse transcribed using SuperScript III 158 
(Invitrogen, Carlsbad, CA, USA). The quantification of gene expression was performed 159 
by quantitative RT-PCR using the Mx3000P QPCR System (Agilent Technologies, 160 
Santa Clara, CA, USA) and QuantiTect SYBR Green PCR Kit (QIAGEN). Specific 161 
primers for IL-4, IL-13, IL-18, IFN- and GAPDH were obtained from QIAGEN 162 
(QuantiTect Primer Assay). The cycling conditions were as follows: incubation for 5 163 
min at 95°C and 40 cycles of 10 s at 95°C and 30 s at 60°C. The dates were normalised 164 
to GAPDH. Each experiment was performed in triplicate, and the mean was adopted as 165 
the value in each experiment.  166 
 167 
2.6. Dual fluorescent immunostaining of IL-13 and IFN- 168 
IL-18 has the potential to induce Th2 cytokine production by Th1 cells [21]. In 169 
other words, super Th1 cells are capable of producing both Th1 and Th2 cytokines [21]. 170 
To further investigate whether cells that produce both Th1 and Th2 cytokines exist in 171 
submandibular glands of patients with IgG4-RD, we examined dual 172 
immunofluorescence staining of IL-13 as a Th2 cytokine and IFN- as a Th1 cytokine 173 
in six samples from patients with IgG4-RD. 174 
All formalin-fixed and paraffin-embedded specimens of six cases of IgG4-RD 175 
were used for dual fluorescent immunostaining of IL-13 and IFN-. The deparaffinised 176 
sections were microwaved in citrate buffer (pH 6.0) for 20 min and incubated in protein 177 
block solution (Dako) for 20 min. Deparaffinised sections were treated with 3% 178 
hydrogen peroxide for 10 min to inactivate endogenous peroxidase activity. Specimens 179 
were incubated with a rabbit anti-human IL-13 antibody (06-1090, 1:500, 180 
MILLIPORE) and a mouse anti-human IFN- antibody (clone25718, 1:10, R&D 181 
Systems, MN, USA) overnight at 4°C. The reaction product was visualised with 182 
fluorescent goat anti-rabbit Alexa Fluor 488 and anti-mouse Alexa Fluor 594 IgG 183 
secondary antibodies (1:500, Invitrogen). Specimens were counterstained with 4′, 184 
6-diamidino-2-phenylindole (Invitrogen). No positive staining was observed when the 185 
primary antibodies were omitted or replaced with normal serum in the negative controls 186 
during staining procedures.  187 
 188 
2.7. Statistical analysis 189 
IBM SPSS Statistics version 19 (IBM, Armonk, NY, USA) was used for data 190 
analysis. IL-18 expression was analysed using Fisher’s exact test and the chi-square test. 191 
The relationships between the expression scores of IL-4, IL-13, IL-18 and IFN- were 192 
analysed with Spearman’s rank correlation coefficient.  193 
The differences of mRNA levels of IL-4, IL-13, IL-18 and IFN- were 194 
analysed using the Mann–Whitney U test. The relationship between the mRNA level of 195 
IL-4, IL-13, IL-18 and IFN- was analysed using Spearman’s rank correlation 196 
coefficient. p values of <0.05 were considered statistically significant.  197 
 198 
3. Results 199 
3.1. Main clinical data 200 
 Main clinical data of patients with IgG4-RD, controls of LN and controls of 201 
submandibular glands are shown in Table 1. Of the 20 patients with IgG4-RD, 15 202 
patients had complications. Aside from submandibular glands, the affected organs were 203 
pancreas (five cases), bile duct (one case), lacrimal gland (six cases), parotid gland 204 
(three cases), lung (six cases), kidney (three cases), retroperitoneum (one case), aorta 205 
(four cases), LN (three cases) and skin (one case). The cases who affected only 206 
submandibular gland were five cases.  207 
 We confirmed the diagnosis of IgG4-RD based on laboratory data and 208 
immunohistochemical analysis (Table 1, Figure 1). The serum IgG4 level (normal range, 209 
<135 mg/dL) was increased in all patients with IgG-RD. All the serum IgG4/IgG 210 
proportions in IgG4-RD cases were >10%. The serum IgE levels (normal range, <170 211 




 cells in 212 
pathological specimens of all IgG4-RD cases were > 40%.  213 
 214 
3.2. IL-18 is expressed in inflammatory infiltrates in IgG4-RD 215 
IL-18 was remarkably expressed in inflammatory infiltrates of samples from 216 
patients with IgG4-RD. Eventually, 17 of 20 cases were categorized in the positive 217 
cohort. On the other hand, in controls of LN, only 9 of 19 cases were categorized in the 218 
positive cohort (p < 0.05, Table 1, Figure 2). In controls of submandibular glands, only 219 
8 of 30 were categorized in the positive cohort (p < 0.01, Table1, figures are not 220 
shown).  221 
 222 
3.3. IL-18 expression correlates with IL-13 and IFN-expression 223 
We next investigated the relationship between IL-18 and either Th1 or Th2 224 
cytokines. In this manner, we evaluated expression scores of IL-4, IL-13 and IFN- at 225 
inflammatory infiltrates in submandibular glands from IgG4-RD patients and controls 226 
of LN.  227 
There was no correlation between IL-18 and IL-4 (r = 0.477, p = 0.08, Figure 228 
3) in IgG4-RD cases. In contrast, the expression of IL-18 was significantly associated 229 
with that of IL-13 (r = 0.71, p < 0.01, Figure 3). Finally, there was a significant 230 
correlation between IL-18 and IFN-expression, although the expression level of IFN- 231 
was weak (r = 0.493, p = 0.027, Figure 3). On the other hand, in controls of LN, the 232 
expression of IL-18 was not associated with that of the other cytokines. There were 233 
correlation between IL-4 and IFN- in both IgG4-RD cases and control cases.  234 
 235 
3.4. Level of IL-18 mRNA increases in submandibular glands of IgG4-RD  236 
 We analysed mRNA levels of IL-18, IL-13, IL-4 and IFN- in submandibular 237 
glands of IgG4-RD and pleomorphic adenoma by qRT-PCR (Figure 4). The IL-18 238 
mRNA levels were significantly higher in submandibular glands of patients with 239 
IgG4-RD than in those of pleomorphic adenoma (p < 0.05, Mann–Whitney U test). 240 
Similarly, both IL-4 and IFN-mRNA levels were higher in submandibular glands of 241 
patients with IgG4-RD (p < 0.05). However, there was no significant difference in the 242 
IL-13 mRNA levels between IgG4-RD and pleomorphic adenoma (p = 0.836).  243 
 In addition, we investigated the relationship among mRNA levels of IL-18 and 244 
IFN- as Th1 cytokines and IL-4 and IL-13 as Th2 cytokines. As expected, there was a 245 
remarkable correlation between mRNA levels of IL-18 and IFN- (r = 0.893, p < 0.01). 246 
Although there was no correlation between IL-18 and IL-13 (r = 0.143, p = 0.760), the 247 
expression of IL-18 was closely associated with that of IL-4 (r = 0.714, p = 0.071).  248 
 249 
3.5. Evaluation of IL-13- and IFN--positive cells in submandibular glands 250 
As shown in Figure 5, a few numbers of cells were double positive for IL-13 251 
and IFN-, staining at inflammatory infiltrates in submandibular glands of patients with 252 
IgG4-RD (Figure 5). Both IL-13- and IFN--positive cells in submandibular glands of 253 
IgG4-RD suggest the existence of super Th1 cells.  254 
 255 
4. Discussion 256 
To the best of our knowledge, this is the first study to show that IL-18 257 
expression is increased in submandibular glands of patients with IgG4-RD. This finding 258 
raises the question of what is the function of IL-18 in IgG4-RD.  259 
IL-18 was originally identified as a factor that enhances IFN- production from 260 
Th1 cells [14, 15]. In studies of bronchial asthma, it was well known that IL-18 was 261 
abundantly stored in epithelial cells of various organs, including bronchial epithelial 262 
cells [22, 23, 24]. Sugimoto et al. showed that adoptively transferred memory-type Th1 263 
cells induced airway inflammation in the lung without airway hyperresponsiveness 264 
(AHR) when stimulated with an antigen (Ag). In contrast, memory Th1 cells induced 265 
both severe airway inflammation and AHR when stimulated with Ag and IL-18. IL-18 266 
stimulated antigen-specific cloned Th1 cells to produced IL-13[13]. These cloned Th1 267 
cells produced IL-13 dependent on the doses of IL-18 used for stimulation. However, 268 
these Th1 cells did not produce IL-4 when they were stimulated with IL-18. Notably, 269 
cloned Th2 cells in this study did not produce either IL-4 or IL-13 when they were 270 
stimulated with IL-18. Surprisingly, Ag plus IL-18-stimulated Th1 cells produced 271 
IFN- and IL-13, suggesting that they played a relevant role in the induction of 272 
bronchial asthma [13]. Moreover, Terada et al. demonstrated that Th1 cells induced 273 
intrinsic atopic dermatitis by the production of Th1 and Th2 cytokines and chemokines 274 
[25]. Based on this unique function of Th1 cells, Nakanishi et al. proposed to designate 275 
them as ‘super Th1 cells’ [16]. According to these studies, super Th1 cells produced 276 
IL-13 and not IL-4 [16].  277 
Our present study showed that IL-18 was highly expressed in submandibular 278 
glands of patients with IgG4-RD with both protein and mRNA levels. In addition, there 279 
was a correlation between the expression of IL-18 and IL-13 but not IL-4 in IgG4-RD 280 
with protein levels (Figure 3). However, there was no correlation between mRNA 281 
levels of IL-18 and IL-13. We speculate that this discrepancy can be explained by the 282 
small number of samples that is insufficient to analyse the relationship between mRNA 283 
levels of IL-18 and IL-13. It has been previously reported that there were very few 284 
IL-18 receptors on Th2 cells [26]. Therefore, we hypothesized that Th1 cells were 285 
stimulated by IL-18 to produce IL-13. These Th1 cells that produce Th2 cytokines have 286 
been named super Th1 cells. Our data suggest that IL-13 is produced by super Th1 cells 287 
and not Th2 cells. Moreover, in our dual immunofluorescence staining data, a few 288 
numbers of cells were double-positive for IL-13 and IFN- staining at inflammatory 289 
infiltrates in patients with IgG4-RD (Figure 4). This finding is assured that a possible 290 
existence of super Th1 cells in submandibular glands of patients with IgG4-RD.  291 
There was a correlation between the expression of IL-4 and IFN- in 292 
submandibular glands of IgG4-RD patients and in reactive LNs of control cases with 293 
protein levels. This phenomenon indicated that submandibular glands of IgG4-RD and 294 
reactive LNs have a similar environment for immune reactions of Th1 and Th2 cells. 295 
However, there were difference of IL-18 expression and difference of correlative 296 
relationship of IL-18 and other cytokines between IgG4-RD and reactive LNs. Because 297 
of this reason, IL-18 is considered to be related to the pathogenesis of atypical 298 
inflammation of IgG4-RD.  299 
In the present study, IL-18 stained strongly in specimens from submandibular 300 
glands of patients with IgG4-RD. We speculate that IL-18 acts as a reinforcement of the 301 
immune reaction of Th2 cytokines in IgG4-RD. In addition, super Th1 cells may play a 302 
role in the pathogenesis of IgG4-RD from the perspective of Th2 cytokine production.  303 
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Figure Legends 396 
Figure 1.  397 
IgG and IgG4 expression in inflammatory infiltrates in the submandibular glands 398 
of patients with IgG4-RD  399 
Immunostaining of IgG (A) and IgG4 (B) in submandibular glands of IgG4-RD. 400 
Magnification (A, B) ×200. All patients with IgG4-RD satisfied the comprehensive 401 
diagnostic criteria for IgG4-RD proposed by the All Japan IgG4 team in 2011.  402 
 403 
Figure 2.  404 
IL-18 expression in inflammatory infiltrates in the submandibular glands of 405 
patients with IgG4-RD  406 
Immunostaining of IL-18 in submandibular glands of IgG4-RD (A, B) and controls of 407 
LN (C, D). Magnification (A, C) ×100, (B, D) ×200. IL-18 was strongly expressed in 408 
inflammatory infiltrates of submandibular glands of patients with IgG4-RD. In contrast, 409 
there was sparse expression of IL-18 in inflammatory infiltrates of controls of LN.  410 
 411 
Figure 3.  412 
IL-18 expression correlates with IL-13 and IFN-γ expression in submandibular 413 
glands of patients with IgG4-RD  414 
Immunostaining of IL-4 (A, D), IL-13 (B, E) and IFN- (C,F) in submandibular glands 415 
of patients with IgG4-RD (A-C) and controls of LN (D-F). Magnification, ×200 (A-F). 416 
There was a strong expression of IL-4 and IL-13 in inflammatory infiltrate of 417 
submandibular glands of patients with IgG4-RD (A, B). The relationships between the 418 
expression score of IL-18, IL-4, IL-13 and IFN- were analysed with Spearman’s rank 419 
correlation coefficient (G-N).  420 
(G) Correlation between IL-18 and IL-4 expression scores in IgG4-RD. (H) IL-18 and 421 
IL-13 in IgG4-RD. (I) IL-18 and IFN- in IgG4-RD. (J) IL-4 and IFN- in IgG4-RD. 422 
(K) IL-18 and IL-4 in controls of LN. (L) IL-18 and IL-13 in controls of LN. (M) IL-18 423 
and IFN- in controls of LN. (N) IL-4 and IFN- in controls of LN.  424 
 425 
Figure 4.  426 
Level of IL-18 mRNA increases in submandibular glands of IgG4-RD  427 
Expression levels of IL-18, IL-13, IL-4 and IFN- were examined in submandibular 428 
glands of IgG4-RD or pleomorphic adenoma. The relative expression level of samples 429 
from P1, one of IgG4-RD cases, was defined as 1. Black columns: seven cases of 430 
IgG4-RD; white columns: six cases of control. Levels of IL-18 (A), IL-13 (B), IL-4 (C) 431 
and IFN- (D) mRNAs are shown. *: p < 0.05.  432 
Levels of IL-18 mRNA were significantly higher in submandibular glands of patients 433 
with IgG4-RD than in those of pleomorphic adenoma. Similarly, levels of IL-4 and 434 
IFN- mRNA were higher in submandibular glands of patients with IgG4-RD. There 435 
was no statistically significant difference in levels of IL-13 mRNA between IgG4-RD 436 
and pleomorphic adenoma (p = 0.836). 437 
 438 
Figure 5.  439 
Evaluation of IL-13- and IFN--positive cells in submandibular glands  440 
Dual-fluorescent immunostaining of IL-13 (A), IFN- (B) and DAPI (C) in 441 
submandibular glands of IgG4-RD. IL-13 and IFN- were co-expressed in 442 
inflammatory infiltrates of submandibular glands. Original magnification: × 200. Both 443 
IL-13 and IFN-γ-positive cells in submandibular glands of IgG4-RD suggest existence 444 




Table 1. Patient characteristics 449 
n.d., not determined.  450 
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Age at diagnosis 
(years ± SD)
60.3 ± 11.0 52.4 ± 19.9 0.171 53.6 ± 16.9 0.331
Gender
Female 6 10 17
Male 14 9 0.200 13 0.064
Serum IgG4 (mg/dL) 663.1 ± 475.1 n.d n.d
Serum IgG (mg/dL) 1870.2 ± 702.8 n.d n.d




65.9 ±20.0 n.d n.d
IL-18 expression score
IL-18 positive 17 9 8
IL-18 negative 3 10 < 0.05 22 < 0.01
Table(s)
